1 374 170 AYURVEDA BODY-MIND CONSTITUTIONAL TYPES AND ROLE OF YOGA INTERVENTION AMONG TYPE 2 DIABETES MELLITUS POPULATION OF CHANDIGARH AND PANCHKULA REGIONS. BACKGROUND: TYPE 2 DIABETES NEEDS A BETTER UNDERSTANDING OF ETIOLOGICAL FACTORS AND MANAGEMENT STRATEGIES BASED ON LIFESTYLE AND CONSTITUTIONAL FACTORS, GIVEN ITS HIGH ASSOCIATION RATE WITH MANY CARDIOVASCULAR, NEUROLOGICAL DISORDERS, AND COVID-19 INFECTION. PURPOSE: THE PRESENT STUDY WAS UNDERTAKEN TO INVESTIGATE THE EFFECT OF DIABETES-SPECIFIC INTEGRATED YOGA LIFESTYLE PROTOCOL (DYP) ON GLYCEMIC CONTROL AND LIPID PROFILES OF DIABETIC ADULTS. ALONG WITH THE DYP INTERVENTION, THE INDIVIDUALS RESIDING IN CHANDIGARH AND PANCHKULA UNION TERRITORIES IN THE NORTHERN PART OF INDIA WERE ASSESSED FOR AYURVEDA-BASED BODY-MIND CONSTITUTIONAL TYPE. AYURVEDA DESCRIBES BODY-MIND CONSTITUTION AS "PRAKRITI," WHICH HAS BEEN DISCUSSED FROM TWO ANGLES, NAMELY PHYSIOLOGICAL AND PSYCHOLOGICAL AS BODY AND MIND ARE CORRELATED. METHODS: CLUSTER SAMPLING OF WAITLIST CONTROL STUDY SUBJECTS WAS USED AS THE SAMPLING METHOD FOR THE STUDY. A TOTAL OF 1,215 REGISTERED SUBJECTS (81 DIABETIC) RESPONDED IN RANDOMLY SELECTED CLUSTERS IN CHANDIGARH AND PANCHKULA. AYURVEDA PHYSICIANS DID AYURVEDA BODY-MIND CONSTITUTIONAL ASSESSMENT CALLED PRAKRITI ASSESSMENT (PHYSIOLOGICAL BODY-MIND CONSTITUTION ASSESSMENT) IN 35 PARTICIPANTS (23 DIABETIC, 12 PREDIABETIC) AS A PART OF THE STUDY. RESULTS: A GROUP OF 50 SUBJECTS WAS RANDOMLY SELECTED FOR YOGA INTERVENTION OUT OF 81 DIABETES MELLITUS ADULTS, AND 31 SUBJECTS WERE ENROLLED AS WAITLIST CONTROLS. A SIGNIFICANT DECREASE IN THE GLYCOSYLATED HEMOGLOBIN LEVELS FROM 8.49 +/- 1.94% TO 7.97 +/- 2.20% IN THE INTERVENTION GROUP WAS NOTICED. THE LIPID PROFILES OF THE DYP INTERVENTION AND CONTROL GROUPS WERE MONITORED. THREE-MONTH FOLLOW-UP RESULTS OF LIPID PROFILE DIAGNOSTIC TESTS IN INTERVENTION AND CONTROL GROUPS SHOWED A SIGNIFICANT DIFFERENCE BETWEEN THE TWO GROUPS (P < 0.05). MOST DIABETIC AND PREDIABETIC INDIVIDUALS WERE FOUND TO HAVE PITTA DOSHA (PITTA CONTROLS ALL HEAT, METABOLISM, AND TRANSFORMATION IN THE MIND AND BODY) AS DOMINANT CONSTITUTION TYPE. CONCLUSION: THE STUDY RESULTS DEMONSTRATED SIGNIFICANT POSITIVE EFFECTS OF YOGA IN DIABETIC INDIVIDUALS. THIS STUDY HAS INDICATED THE EVIDENCE FOR THE SAFETY AND EFFICACY OF THE VALIDATED DYP FOR COMMUNITY-LEVEL INTERVENTIONS TO PREVENT MALADIES LIKE BRAIN DAMAGE AND STROKE. 2020 2 496 30 COMBINATION OF AYURVEDA AND YOGA THERAPY REDUCES PAIN INTENSITY AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH MIGRAINE HEADACHE. OBJECTIVES: TO UNDERSTAND THE EFFICACY OF AYURVEDA AND YOGA IN THE MANAGEMENT OF MIGRAINE HEADACHE. METHODS: 30 SUBJECTS RECRUITED TO AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATORY PROCESS) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NSAID'S) FOR 90 DAYS. BODY CONSTITUTION QUESTIONNAIRE WAS ADMINISTERED TO BOTH GROUPS. THE OUTCOME MEASURES INCLUDED SYMPTOM CHECK LIST, COMPREHENSIVE HEADACHE RELATED QUALITY OF LIFE QUESTIONNAIRE AND VISUAL ANALOGUE SCALE. RESULTS: FORTY-SIX (76.6%) OUT OF 60 SUBJECTS BELONGING TO BOTH GROUPS HAD PITTA BASED BODY CONSTITUTION. FOLLOWING 90 DAYS OF INTERVENTION THE AY GROUP SHOWED SIGNIFICANT REDUCTION IN MIGRAINE SYMPTOMS INCLUDING PAIN INTENSITY (P<.001) AND IMPROVEMENT IN HEADACHE RELATED QUALITY OF LIFE (P<.001). THE CT GROUP SHOWED NO SIGNIFICANT CHANGE (P>.05). CONCLUSION: TRADITIONAL AYURVEDA ALONG WITH YOGA THERAPY REDUCES SYMPTOMS, INTENSITY OF PAIN AND IMPROVES QUALITY OF LIFE IN MIGRAINE PATIENTS. 2018 3 453 32 CHANGES IN MIDAS, PERCEIVED STRESS, FRONTALIS MUSCLE ACTIVITY AND NON-STEROIDAL ANTI-INFLAMMATORY DRUGS USAGE IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA FOLLOWING AYURVEDA AND YOGA COMPARED TO CONTROLS: AN OPEN LABELED NON-RANDOMIZED STUDY. BACKGROUND: THERE HAS BEEN A SIGNIFICANT INCREASE IN THE USE OF COMPLEMENTARY AND INTEGRATIVE MEDICINE TO PROVIDE LONG-TERM HEALING SOLUTIONS IN MIGRAINE HEADACHE PATIENTS. KNOWING THE LIMITATIONS OF CONVENTIONAL MEDICAL APPROACH, THE PRESENT STUDY EVALUATED THE INFLUENCE OF TWO INDIAN TRADITIONAL SYSTEMS OF MEDICINE ON MIGRAINE-RELATED DISABILITY, AUTONOMIC VARIABLES, PERCEIVED STRESS, AND MUSCLE ACTIVITY IN PATIENTS WITH MIGRAINE HEADACHE WITHOUT AURA. METHODS: THIRTY SUBJECTS RECRUITED TO THE AYURVEDA AND YOGA (AY) GROUP UNDERWENT TRADITIONAL PANCHAKARMA (BIO-PURIFICATION) USING THERAPEUTIC PURGATION FOLLOWED BY YOGA THERAPY, WHILE 30 SUBJECTS OF CONTROL (CT) GROUP CONTINUED ON SYMPTOMATIC TREATMENT (NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [NSAID'S]) FOR 90 DAYS. MIGRAINE DISABILITY ASSESSMENT SCORE, PERCEIVED STRESS, HEART RATE VARIABILITY (HRV), AND SURFACE ELECTROMYOGRAPHY (EMG) OF FRONTALIS MUSCLE WERE MEASURED ON DAY 1, DAY 30, AND DAY 90 IN BOTH GROUPS. RESULTS: SIGNIFICANT REDUCTION IN MIGRAINE DISABILITY AND PERCEIVED STRESS SCORES WERE OBSERVED IN THE AY GROUP. THE LOW-FREQUENCY COMPONENT OF THE HRV DECREASED SIGNIFICANTLY, THE HIGH-FREQUENCY COMPONENT INCREASED AND THEIR RATIO SHOWED IMPROVED SYMPATHOVAGAL BALANCE. THE EMG SHOWED DECREASED ACTIVITY OF THE FRONTALIS MUSCLE IN THE AY GROUP COMPARED TO THE CONTROL GROUP. CONCLUSION: THE INTEGRATIVE APPROACH COMBINING AYURVEDA AND YOGA THERAPY REDUCES MIGRAINE-RELATED DISABILITY, PERCEIVED STRESS, SYMPATHETIC AROUSAL, AND MUSCLE TENSION. 2018 4 689 49 EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN PREDIABETIC AND TYPE 2 DIABETES UNDER THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS)-AYUSH INTEGRATION PROJECT. BACKGROUND: TYPE 2 DIABETES IS A LIFESTYLE-RELATED DISORDER THAT AFFECTS AROUND 422 MILLION INDIVIDUALS IN INDIA. INTEGRATION OF AYUSH (AYURVEDA) WITH THE NATIONAL PROGRAMME FOR PREVENTION AND CONTROL OF CANCER, DIABETES, CARDIOVASCULAR DISEASES AND STROKE (NPCDCS) WAS CONCEIVED ON PILOT BASIS AT GAYA, BIHAR, TO PROVIDE INTEGRATIVE TREATMENT FOR NON-COMMUNICABLE DISEASE PATIENTS AND TO MANAGE THE BURDEN OF NON-COMMUNICABLE DISEASES IN INDIA. OBJECTIVES: THE OBJECTIVE OF THIS STUDY WAS TO ANALYZE THE EFFECT OF AYURVEDA INTERVENTION, LIFESTYLE MODIFICATION AND YOGA IN THE MANAGEMENT OF TYPE 2 DIABETES UNDER NPCDCS-AYUSH INTEGRATION PROJECT. MATERIALS AND METHODS: A MULTI-CENTRIC, OPEN-LABELED, PROSPECTIVE, COMPARATIVE CLINICAL STUDY WAS CONDUCTED AT 17 COMMUNITY HEALTH CENTERS AND 1 DISTRICT HOSPITAL. POPULATION OVER 30 YEARS OF AGE WAS SCREENED AND PREDIABETIC OR TYPE 2 DIABETIC INDIVIDUALS WERE ENROLLED IN TWO COHORTS, I.E., PRE-DIABETIC (COHORT A) AND TYPE 2 DIABETIC (COHORT B). EACH COHORT WAS FURTHER DIVIDED INTO TWO GROUPS: GROUP A1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA AND GROUP A2 WAS GIVEN AYURVEDA MEDICATION IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA. SIMILARLY, GROUP B1 WAS ADVISED FOR LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION AND GROUP B2 WAS GIVEN AYURVEDA MEDICATION, I.E., MAMAJJAKA, AMALAKI AND GUDUCHI POWDER IN ADDITION TO LIFESTYLE MODIFICATION AND YOGA ALONG WITH ALLOPATHIC MEDICATION. TREATMENT WAS GIVEN FOR 6 MONTHS. DATA WERE ANALYZED THROUGH PAIRED T-TEST. RESULTS: A SIGNIFICANT REDUCTION WAS OBSERVED IN FASTING BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001) AND ALSO IN THE POSTPRANDIAL BLOOD SUGAR LEVEL IN GROUPS A2 AND B2 (P = 0.001). FURTHER, IMPROVEMENT IN SUBJECTIVE SYMPTOMS SUCH AS POLYURIA, POLYDIPSIA, POLYPHAGIA, BLURRED VISION AND WEAKNESS WAS FOUND IN ALL THE GROUPS, WHILE NON-HEALING ULCER DOES NOT SHOW ANY IMPROVEMENT. CONCLUSION: THE STUDY REVEALS THAT AYURVEDA INTERVENTION, I.E., MAMAJJAKA CHURNA (1 G), AMALAKI CHURNA (3 G) AND GUDUCHI CHURNA (3 G) TWO TIMES A DAY EFFECTIVELY CONTROLS BLOOD SUGAR LEVEL IN PRE-DIABETIC AND TYPE 2 DIABETIC PATIENTS AND IMPROVES THE DISEASE MANAGEMENT WITH LIFESTYLE MODIFICATION AND YOGASANA AS WELL AS WITH ALLOPATHIC TREATMENT. 2019 5 1116 48 EFFICACY OF A VALIDATED YOGA PROTOCOL ON DYSLIPIDEMIA IN DIABETES PATIENTS: NMB-2017 INDIA TRIAL. BACKGROUND: DYSLIPIDEMIA IS CONSIDERED A RISK FACTOR IN TYPE 2 DIABETES MELLITUS (T2DM) RESULTING IN CARDIO-VASCULAR COMPLICATIONS. YOGA PRACTICES HAVE SHOWN PROMISING RESULTS IN ALLEVIATING TYPE 2 DIABETES PATHOLOGY. METHOD: IN THIS STRATIFIED TRIAL ON A YOGA BASED LIFESTYLE PROGRAM IN CASES WITH TYPE 2 DIABETES, IN THE RURAL AND URBAN POPULATION FROM ALL ZONES OF INDIA, A TOTAL OF 17,012 ADULTS (>20 YEARS) OF BOTH GENDERS WERE SCREENED FOR LIPID PROFILE AND SUGAR LEVELS. THOSE WHO SATISFIED THE SELECTION CRITERIA WERE TAUGHT THE DIABETES YOGA PROTOCOL (DYP) FOR THREE MONTHS AND THE DATA WERE ANALYZED. RESULTS: AMONG THOSE WITH DIABETES, 29.1% HAD ELEVATED TOTAL CHOLESTEROL (TC > 200 MG/DL) LEVELS THAT WERE HIGHER IN URBAN (69%) THAN RURAL (31%) DIABETES PATIENTS. THERE WAS A POSITIVE CORRELATION (P = 0.048) BETWEEN HBA1C AND TOTAL CHOLESTEROL LEVELS. DYP INTERVENTION HELPED IN REDUCING TC FROM 232.34 +/- 31.48 MG/DL TO 189.38 +/- 40.23 MG/DL WITH SIGNIFICANT PRE POST DIFFERENCE (P < 0.001). CONVERSION RATE FROM HIGH TC (>200 MG/DL) TO NORMAL TC (<200 MG/DL) WAS OBSERVED IN 60.3% OF CASES WITH TYPE 2 DIABETES MELLITUS (T2DM); FROM HIGH LDL (>130 MG/DL) TO NORMAL LDL (<130 MG/DL) IN 73.7%; FROM HIGH TRIGLYCERIDE (>200 MG/DL) TO NORMAL TRIGLYCERIDE LEVEL (<200 MG/DL) IN 63%; FROM LOW HDL (<45 MG/DL) TO NORMAL HDL (>45 MG/DL) IN 43.7% OF T2DM PATIENTS AFTER THREE MONTHS OF DYP. CONCLUSIONS: A YOGA LIFESTYLE PROGRAM DESIGNED SPECIFICALLY TO MANAGE DIABETES HELPS IN REDUCING THE CO-MORBIDITY OF DYSLIPIDEMIA IN CASES OF PATIENTS WITH T2DM. 2019 6 1128 38 EFFICACY OF VAMANA KARMA WITH IKSHVAKU KSHEERA YOGA IN THE MANAGEMENT OF TAMAKA SHVASA (BRONCHIAL ASTHMA). INTRODUCTION: BRONCHIAL ASTHMA IS A HIGHLY PREVALENT DISEASE, AND IN MOST OF THE ETIOPATHOGENESIS AND SYMPTOMATOLOGY, IT CAN BE CORRELATED WITH TAMAKA SHVASA. IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY.) IS AN ANNUAL HERBACEOUS CLIMBING PLANT WITH A LONG HISTORY OF MEDICINAL USES FOR THE TREATMENT OF VARIOUS AILMENTS INCLUDING JAUNDICE, DIABETES, ULCER, PILES, COLITIS, ASTHMA, INSANITY, HYPERTENSION, CONGESTIVE CARDIAC FAILURE AND SKIN DISORDERS. ITS FRUIT PULP IS USED BOTH AS AN EMETIC AND AS A PURGATIVE. AIMS: TO STUDY THE EFFICACY OF VAMANA KARMA WITH IKSHVAKU (LAGENARIA VULGARIS [MANILA] STANDLEY) KSHEERA YOGA. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS FULFILLING THE DIAGNOSTIC CRITERIA FOR BRONCHIAL ASTHMA WERE SELECTED FROM OUTPATIENT AND INPATIENT DEPARTMENT OF PANCHAKARMA DEPARTMENT. THE SIGN AND SYMPTOMS, MAINLY BREATHLESSNESS, COUGH AND RHONCHI WERE GIVEN SCORES DEPENDING ON THEIR SEVERITY. THE PATIENTS WERE ALSO ASSESSED FOR LUNG FUNCTION TEST TO DETERMINE PULMONARY IMPAIRMENT. FOR VAMANA, THEY WERE GIVEN DEEPANA AND PACHANA WITH TRIKATU CHURNA FOR 3 DAYS AND THEN THEY WERE SUBJECTED TO SNEHAPANA WITH LUKEWARM COW'S GHEE. AFTER THE COMPLETION OF SNEHAPANA, THE PATIENT WERE GIVEN ABHYANGA, VASHPA SWEDANA AND DIET WITH PREDOMINANCE OF KAPHA (KAPHA BAHULA AHARA- DIET MIXED WITH MILK OR CURD), WHICH WAS THEN FOLLOWED BY VAMANA WITH IKSHVAKU KSHEERA YOGA AND SAMSARJANA KRAMA. FOLLOW-UP WAS DONE AT AN INTERVAL OF 15 DAYS FOR THREE TIMES AND T SCORES WERE NOTED BEFORE AND AFTER THE TREATMENT. THE SCORES WERE ANALYZED USING WILCOXON SIGNED-RANK TEST FOR SUBJECTIVE PARAMETERS AND STUDENT'S PAIRED T-TEST FOR OBJECTIVE PARAMETERS. RESULTS: THE TRIAL DRUG HAS SHOWN STATISTICALLY HIGHLY SIGNIFICANT REDUCTION IN BREATHLESSNESS, COUGH, RHONCHI, AND SIGNIFICANT CHANGES IN LUNG FUNCTION TESTS. CONCLUSION: THE TEST DRUG PROVED ITS EMETIC EFFECT ON THE PATIENTS OF BRONCHIAL ASTHMA AND THUS RELIEVED THE SYMPTOMS OF THE DISEASE IMMEDIATELY. IT HAS REDUCED FREQUENCY OF EPISODES OF BREATHLESSNESS AND SEVERITY OF SYMPTOMS. 2017 7 1703 40 PARTITIONING OF RADIOLOGICAL, STRESS AND BIOCHEMICAL CHANGES IN PRE-DIABETIC WOMEN SUBJECTED TO DIABETIC YOGA PROTOCOL. BACKGROUND: YOGA IS AN ANCIENT SYSTEM OF WELLNESS WITH ASANA AND PRANAYAMA AS ITS MOST POPULAR AND PROPAGATED MODULES FOR MANAGEMENT OF LIFESTYLE DISORDERS. OBJECTIVES: THE AIM OF THE STUDY WAS TO CHARACTERISE THE LIVER ABNORMALITIES, BIOCHEMICAL CHANGES, AND STRESS LEVELS AFTER YOGA INTERVENTION IN PREDIABETIC FEMALES. MATERIALS AND METHODS: 37 FEMALES WERE RANDOMLY DIVIDED INTO YOGA PRACTISING AND NON-PRACTISING CONTROL GROUPS. THE YOGA PRACTISING GROUP PERFORMED DIABETIC YOGA PROTOCOL (DYP) FOR 3 MONTHS. PARAMETERS INCLUDING SIZE OF LIVER, FATTY INFILTRATION, AND GRADE OF SEVERITY WERE MEASURED USING ULTRASONOGRAPHY ALONG WITH BIOCHEMICAL PARAMETERS AND STRESS LEVELS AT BASELINE AND AFTER YOGA PRACTICE. RESULTS: THE GLYCOSYLATED HEMOGLOBIN (HBA1C) AND GLUCOSE LEVELS WERE FOUND SIGNIFICANTLY REDUCED IN PREDIABETIC (P=0.015) WOMEN AFTER PRACTISING DYP, ALTHOUGH CHOLESTEROL LEVELS INCREASED IN MENOPAUSAL WOMEN. NO ESCALATION OF FATTY LIVER WAS NOTED AMONG WOMEN PRACTISING DYP. CONCLUSION: DYP REDUCED THE HBA1C AND STRESS LEVELS AND THEREFORE, COULD BE A COST-EFFECTIVE TOOL FOR PREVENTING PREDIABETES TO DIABETES PROGRESSION. 2019 8 625 46 DIABETIC YOGA PROTOCOL IMPROVES GLYCEMIC, ANTHROPOMETRIC AND LIPID LEVELS IN HIGH RISK INDIVIDUALS FOR DIABETES: A RANDOMIZED CONTROLLED TRIAL FROM NORTHERN INDIA. PURPOSE: TO STUDY THE EFFECTIVENESS OF DIABETIC YOGA PROTOCOL (DYP) AGAINST MANAGEMENT OF CARDIOVASCULAR RISK PROFILE IN A HIGH-RISK COMMUNITY FOR DIABETES, FROM CHANDIGARH, INDIA. METHODS: THE STUDY WAS A RANDOMIZED CONTROLLED TRIAL, CONDUCTED AS A SUB STUDY OF THE PAN INDIA TRIAL NIYANTRITA MADHUMEHA BHARATH (NMB). THE COHORT WAS IDENTIFIED THROUGH THE INDIAN DIABETES RISK SCORING (IDRS) (>/= 60) AND A TOTAL OF 184 INDIVIDUALS WERE RANDOMIZED INTO INTERVENTION (N = 91) AND CONTROL GROUPS (N = 93). THE DYP GROUP UNDERWENT THE SPECIFIC DYP TRAINING WHEREAS THE CONTROL GROUP FOLLOWED THEIR DAILY REGIMEN. THE STUDY OUTCOMES INCLUDED CHANGES IN GLYCEMIC AND LIPID PROFILE. ANALYSIS WAS DONE UNDER INTENT-TO-TREAT PRINCIPLE. RESULTS: THE 3 MONTHS DYP PRACTICE SHOWED DIVERSE RESULTS SHOWING GLYCEMIC AND LIPID PROFILE OF THE HIGH RISK INDIVIDUALS. THREE MONTHS OF DYP INTERVENTION WAS FOUND TO SIGNIFICANTLY REDUCE THE LEVELS OF POST-PRANDIAL GLUCOSE LEVELS (P = 0.035) AND LDL-C LEVELS (P = 0.014) AND WAIST CIRCUMFERENCE (P = 0.001). CONCLUSION: THE FINDINGS INDICATE THAT THE DYP INTERVENTION COULD IMPROVE THE METABOLIC STATUS OF THE HIGH-DIABETES-RISK INDIVIDUALS WITH RESPECT TO THEIR GLUCOSE TOLERANCE AND LIPID LEVELS, PARTIALLY EXPLAINED BY THE REDUCTION IN ABDOMINAL OBESITY. THE STUDY HIGHLIGHTS THE POTENTIAL ROLE OF YOGA INTERVENTION IN REAL TIME IMPROVEMENT OF CARDIOVASCULAR PROFILE IN A HIGH DIABETES RISK COHORT. TRIAL REGISTRATION: CTRI, CTRI/2018/03/012804. REGISTERED 01 MARCH 2018-RETROSPECTIVELY REGISTERED, HTTP://WWW.CTRI.NIC.IN/ CTRI/2018/03/012804. 2021 9 1178 30 EVALUATION OF STAMBHANAKARAKA YOGA AND COUNSELING IN THE MANAGEMENT OF SHUKRAGATA VATA (PREMATURE EJACULATION). PREMATURE EJACULATION (PE) IS A VERY COMMON MALE SEXUAL PROBLEM. ANXIETY, STRESS, FEAR ETC., ARE THE MAIN PREDISPOSING FACTORS OF PE. IN AYURVEDA, THIS CONDITION CAN BE CORRELATED WITH SHUKRAGATA VATA. IN THE PRESENT STUDY, FIFTY FIVE PATIENTS WITH PE WERE GROUPED INTO TWO AND WERE TREATED WITH STAMBHANAKARAKA YOGA (N = 30) AND PLACEBO (N = 20) FOR A DURATION OF TWO MONTHS, WITH LUKE WARM WATER AS ANUPANA. PSYCHOLOGICAL COUNSELING WAS GIVEN TO THE PATIENTS IN BOTH THE GROUPS. AFTER COMPLETION OF TREATMENT, STAMBHANAKARAKA YOGA SHOWED SIGNIFICANT RESULTS AGAINST PLACEBO IN ALL PARAMETERS, NAMELY INTRAVAGINAL EJACULATION LATENCY TIME (IELT), VOLUNTARY CONTROL OVER EJACULATION, PATIENT AND PARTNER'S SATISFACTION, PERFORMANCE ANXIETY. 2013 10 882 45 EFFECT OF YOGA TRAINING ON LIPID METABOLISM IN INDUSTRIAL WORKERS WITH REFERENCE TO BODY CONSTITUTION (PRAKRITI). INTRODUCTION: THE PROGRESSIVE INCREASE IN DYSLIPIDEMIA AND PHYSICAL INACTIVITY ARE CONSIDERED TO BE MAJOR RISK FACTORS FOR THE ONSET OF NON COMMUNICABLE DISEASES. AWARENESS OF BODY CONSTITUTION PLAYS A VITAL ROLE TO REGULARISE OPTIMUM HEALTH. THE PRESENT STUDY WAS PLANNED TO EVALUATE THE EFFECT OF YOGA PRACTICES ON LIPID METABOLISM WITH REFERENCE TO SPECIFIC BODY CONSTITUTION (PRAKRITI). METHODS: A SELF-AS-CONTROL STUDY WAS CONDUCTED ON 36 MALE HEALTHY VOLUNTEERS BETWEEN AGE GROUP OF 30-58 YEARS. THEIR PRAKRITI ANALYSIS WAS DONE USING STANDARDIZED, VALIDATED QUESTIONNAIRE AND WERE DIVIDED INTO VATA-PITTA (N = 16) AND PITTA-KAPHA (N = 20) GROUPS. THE ASSESSMENT OF LIPID PROFILE WAS DONE IN FASTING BLOOD SAMPLES BEFORE AND AFTER 12 WEEKS OF YOGA TRAINING. DATA WERE ANALYZED USING PAIRED T-TEST AND INDEPENDENT T-TEST. RESULTS: AFTER YOGA INTERVENTION, THE RESULT OF WITHIN GROUP COMPARISON REVEALED THAT IN VATA-PITTA (V-P) GROUP, SIGNIFICANT DECREASE IN THE LEVELS OF TC, LDL (P < 0.001) AND SIGNIFICANT INCREASE IN HDL (P < 0.01) WAS OBSERVED. WHILE, PITTA-KAPHA (P-K) GROUP SHOWED SIGNIFICANT DECREASE IN TC (P < 0.001), TG (P < 0.01), LDL (P < 0.001) AND VLDL (P < 0.05) LEVELS. FURTHER, THE RESULTS BETWEEN GROUPS REVEALED THAT P-K GROUP HAS SIGNIFICANTLY HIGHER BASELINE LEVELS OF TC, TG AND VLDL AS COMPARED TO V-P GROUP (P < 0.05). CONCLUSION: THE STUDY CONCLUDES THAT YOGA PRACTICES CAN EFFECTIVELY REGULATE LIPID METABOLISM AND TOTAL BODY ENERGY EXPENDITURE WITH REFERENCE TO SPECIFIC CONSTITUTIONAL TYPE (PRAKRITI) THAT MAY ACT AS A TOOL TO ASSESS MAGNITUDE OF METABOLIC FUNCTIONS. 2017 11 479 38 CLINICAL EFFECT OF NIRGUNDI PATRA PINDA SWEDA AND ASHWAGANDHADI GUGGULU YOGA IN THE MANAGEMENT OF SANDHIGATA VATA (OSTEOARTHRITIS). SANDHIGATA VATA IS ONE AMONG THE 80 NANATMAJA VATA VYADHIES. SANDHIGATA VATA AND OSTEOARTHRITIS HAVE COMMON SYMPTOMS, AND HENCE, BOTH ARE CONSIDERED AS SIMILAR ENTITIES BY A MAJORITY OF AYURVEDIC SCHOLARS AND SAME HAS BEEN ADOPTED HERE. OSTEOARTHRITIS IS THE MOST COMMON JOINT DISEASE AMONG HUMAN BEINGS TODAY. IN THIS STUDY, A TOTAL OF 116 PATIENTS WERE REGISTERED, OUT OF THEM 101 PATIENTS HAD COMPLETED THE FULL COURSE OF TREATMENT, WHILE 15 PATIENTS LEFT AGAINST MEDICAL ADVICE. THE 101 PATIENTS OF SANDHIGATA VATA WERE TREATED IN TWO GROUPS. GROUP A: IN THIS GROUP 50 PATIENTS OF SANDHIGATA VATA WERE TREATED WITH NIRGUNDI PATRA PINDA SWEDA FOR 21 DAYS AND ASHWAGANDHADI GUGGULU YOGA3 G/DAY FOR 45 DAYS WAS GIVEN ORALLY. GROUP B: IN THIS GROUP 51 PATIENTS OF SANDHIGATA VATA WERE TREATED WITH ONLY ASHWAGANDHADI GUGGULU YOGA 3 G/DAY FOR 45 DAYS. TO ASSESS THE EFFECT OF THE THERAPY OBJECTIVELY, ALL THE SIGNS AND SYMPTOMS OF SANDHIGATA VATA WERE GIVEN A SCORE, DEPENDING UPON THEIR SEVERITY. ALSO FUNCTIONAL TESTS LIKE WALKING TIME, CLIMBING STAIRS, AND JOINT MOVEMENT, WERE MEASURED AS A CRITERIA FOR ASSESSMENT. BOTH THE GROUPS SHOWED GOOD RESULTS, BUT GROUP B SHOWED BETTER RESULTS IN COMPARISON TO GROUP A. 2011 12 2885 44 YOGA: AS AN ADJUNCT THERAPY TO TRIM DOWN THE AYURVEDIC DRUG REQUIREMENT IN NON INSULIN-DEPENDENT DIABETES MELLITUS. INTRODUCTION: IN SPITE OF A LARGE NUMBER OF DRUGS SHOWING ANTI-HYPERGLYCEMIC ACTIVITIES, NONE OF THEM HAVE BEEN SUCCESSFUL IN COMPLETE MANAGEMENT OF DIABETES MELLITUS (DM). YOGA AND AYURVEDA ARE THE TWO SCHOOLS OF THOUGHT IN INDIA, WHICH HAVE A HISTORY OF CURING DISEASES SINCE THOUSANDS OF YEARS. YOGIC TECHNIQUES AND AYURVEDIC HERBS HAVE PROVEN THEIR ANTI-DIABETIC POTENTIAL WITHOUT INDUCING UNTOWARD EFFECTS. THE PRESENT STUDY COMBINES AYURVEDIC MEDICATION WITH YOGA TECHNIQUES AS A NEW APPROACH TOWARD HEALING DM. AIMS AND OBJECTIVES: TO ASSESS THE EFFECT OF YOGA THERAPY IN THE MANAGEMENT OF NON INSULIN-DEPENDENT DM (NIDDM) AND TO DECREASE THE ORAL DRUG DOSE REQUIREMENT OF GUDUCI GHANA TABLET. MATERIALS AND METHODS: THIRTY KNOWN NIDDM PATIENTS OF BOTH GENDERS, WHO WERE ON GUDUCI GHANA (SOLIDIFIED AQUEOUS EXTRACT OF TINOSPORA CORDIFOLIA (WILLD.) MIERS.) TABLETS FROM PAST 2 MONTHS AS AYURVEDIC REMEDY FOR DM WERE SELECTED. ALONG WITH GUDUCI GHANA ADMINISTRATION, THE SUBJECTS WERE INSTRUCTED TO FOLLOW YOGIC PROCEDURES INCLUDING ASANAS, PRANAYAMA, AND SUDDHI KRIYAS. THE STUDY WAS CONDUCTED FOR 8 WEEKS, WHEREIN FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS ALONG WITH RELIEF IN SIGN AND SYMPTOMS WERE ASSESSED AT EVERY 2 WEEKS INTERVALS, AND ACCORDING TO RELIEF IN SIGN AND SYMPTOMS, TAPERING OF DRUG DOSAGE WAS CARRIED OUT. THE OBTAINED DATA WERE ANALYZED STATISTICALLY BY APPLYING PAIRED T-TEST. RESULTS AND CONCLUSION: THE RESULTS OBTAINED WERE PROMISING AS THE RELIEF IN DIABETIC SYMPTOMATOLOGY WAS HIGHLY SIGNIFICANT IN TERMS OF P VALUE. 80.83% REDUCTION IN DOSE OF GUDUCI GHANA TABLETS AND 7.85% AND 8.78% FALL IN FBS AND PPBS LEVELS, RESPECTIVELY, AFTER THE COMPLETE COURSE OF TREATMENT. THE OBTAINED P VALUE SHOWED HIGHLY SIGNIFICANT RESULTS. 2014 13 483 41 CLINICAL EFFICACY OF VAMANA KARMA WITH IKSHWAAKU BEEJA YOGA FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF ARTAVA KSHAYA W. S. R TO POLYCYSTIC OVARIAN SYNDROME. BACKGROUND: DUE TO SEDENTARY LIFESTYLE AND STRESS, THE INCIDENCE OF METABOLIC DISORDERS ARE INCREASING DAY BY DAY. AMONG THESE POLYCYSTIC OVARIAN SYNDROME (PCOS) IS AN INTRICATE DISORDER AFFECTING 4%-8% WOMEN IN THEIR REPRODUCTIVE AGE AND RELATED TO OVARIAN DYSFUNCTION CHARACTERIZED BY OBESITY, OLIGOMENORRHEA, ANOVULATION AND HYPERANDROGENISM. IN MODERN SYSTEM OF MEDICINE, THE AVAILABLE ALLOPATHIC REGIMEN HAS ITS OWN LIMITATIONS, SO IT IS NEED OF TIME TO FIND A SAFE AND EFFECTIVE ALTERNATIVE THERAPY FOR SUCH TYPE OF CONDITION. THE MOST COMMON SYMPTOM IN 85%-90% OF PCOS PATIENTS IS OLIGOMENORRHEA WHICH CAN BE CORRELATED TO ARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) IN AYURVEDA. HENCE, IN THE PRESENT CLINICAL STUDY, VAMANA KARMA (THERAPEUTIC VOMITING) WITH IKSHWAAKU SEED FORMULATION FOLLOWED BY SHATAPUSHPADI GHANAVATI WAS PLANNED. AIMS: TO EVALUATE THE EFFICACY OF VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IN THE MANAGEMENT OF AARTAVA KSHAYA (LOSS OF MENSTRUAL FLUID) W. S. R TO PCOS. MATERIALS AND METHODS: A TOTAL OF 15 PATIENTS OF PCOS WERE CLINICALLY DIAGNOSED AND TREATED BY VAMANA KARMA (THERAPEUTIC VOMITING) PROCEDURE WITH IKSHWAAKU SEED FORMULATION. AFTER COMPLETION OF VAMANA KARMA (THERAPEUTIC VOMITING) AND SAMSARJANA KRAMA, (POST THERAPY DIETARY REGIMEN FOR REVIVAL) SHATAPUSHPADI GHANAVATI 2 VATI (EACH 500 MG) TWICE IN A DAY WITH LUKEWARM WATER WAS GIVEN FOR 45 DAYS. AFTER COMPLETION OF 2-MONTH TRIAL, ASSESSMENT OF THERAPY WAS ESTIMATED BY SUBJECTIVE AND OBJECTIVE PARAMETERS. RESULTS: STATISTICALLY EXTREMELY SIGNIFICANT (P < 0.0001) RESULTS WERE FOUND IN MENSTRUAL IRREGULARITIES, OBESITY, AND BODY MASS INDEX. THE SIGNIFICANT RESULT IN REDUCTION OF NONDOMINANT FOLLICLES (P = 0.01 AND 0.03 FOR RIGHT AND LEFT OVARY, RESPECTIVELY), LOWERING THE FASTING BLOOD SUGAR LEVEL (P = 0.02) AND HIRSUTISM (P = 0.03) WAS FOUND. CONCLUSION: VAMANA KARMA (THERAPEUTIC VOMITING) FOLLOWED BY SHATAPUSHPADI GHANAVATI IS VERY EFFECTIVE IN THE MANAGEMENT OF OBESE PCOS PATIENTS AND INCREASING CHANCES OF CONCEPTION. 2017 14 1665 24 NATUROPATHY AND YOGA FOR IMPROVING QUALITY OF LIFE IN PEMPHIGUS VULGARIS AND MANAGING CO-MORBID TYPE 2 DIABETES: A CASE REPORT. A 57 YEARS OLD MALE PATIENT WAS ADMITTED TO AN INPATIENT NATUROPATHY AND YOGA (N&Y) HOSPITAL, DIAGNOSED WITH PEMPHIGUS VULGARIS (PV) FOR ONE YEAR AND CO-MORBID TYPE 2 DIABETES (T2DM) FOR 10 YEARS, ASSOCIATED WITH POOR QUALITY OF LIFE (QOL). HE WAS ADMINISTERED N&Y THERAPIES FOR 10 DAYS, ALONG WITH CONVENTIONAL MEDICINES. THERE WAS IMPROVED QOL AND REDUCED DOSAGE OF INSULIN, ALONG WITH REDUCTION IN BODY WEIGHT. THESE CHANGES WERE SUSTAINED AND IMPROVED FURTHER DURING THE 60-DAY FOLLOW-UP PERIOD. ALTHOUGH THERE WAS NO IMPROVEMENT IN THE SKIN LESIONS, THE IMPROVEMENT IN QOL INDICATE A POSSIBLE ROLE OF N&Y IN MANAGEMENT OF PV AND T2DM. THIS CASE REPORT ALSO WARRANTS FURTHER STUDIES FOR N&Y IN THE MANAGEMENT OF DERMATOLOGICAL CONDITIONS AS WELL AS METABOLIC SYNDROME. 2020 15 2463 44 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 16 512 36 COMPARATIVE STUDY ON THE EFFECT OF SAPTAMRITA LAUHA AND YOGA THERAPY IN MYOPIA. BACKGROUND: MYOPIA IS VERY COMMON OPHTHALMIC DISEASE ESPECIALLY IN CHILDREN AND ADOLESCENCE. IN AYURVEDIC TEXTS, ONLY BY THE MAIN FEATURE IMPAIRMENT OF DISTANT VISION MYOPIA CAN BE CORRELATED WITH DRISHTIGATA ROGAS (2(ND) PATALGATA TIMIRA). AIM: TO COMPARE THE EFFECT OF SAPTAMRUTA LAUHA AND YOGA THERAPY IN MYOPIA. MATERIALS AND METHODS: IN PRESENT STUDY, A TOTAL 60 PATIENTS WITH AGE GROUP BETWEEN 8 TO 30 YEARS WERE SELECTED RANDOMLY FROM THE OUT-PATIENT DEPARTMENT OF SWASTHAVRITTA AND SHALAKYATANTRA DEPARTMENT OF GOVERNMENT AYURVEDA COLLEGE, TRIVANDRUM, AND WERE DIVIDED IN TWO GROUPS. IN GROUP A, SAPTAMRITA LAUHA 250 MG TWICE DAILY WITH UNEQUAL QUANTITY OF HONEY AND GHRITA WAS ADMINISTERED WHILE IN GROUP B, PATIENTS SUBJECTED TO YOGA THERAPY (JALA NETI, NADI SHODHANA, SHITALI PRANAYAMA AND POINT TRATAK) FOR 3 MONTHS DURATION WITH 1 MONTH FOLLOW-UP. RESULTS AND CONCLUSION: THE RESULT OBTAINED FROM THE STUDY REVEALS THAT THERE IS NO SIGNIFICANT REDUCTION IN THE VISUAL ACUITY AND CLINICAL REFRACTION, BUT ASSOCIATED CHANGES WERE OBSERVED AS REDUCED IN GROUP B WHEN COMPARED TO GROUP A. HOWEVER, RELIEF FROM HEADACHE WAS FOUND TO BE EQUALLY EFFECTIVE IN BOTH THE GROUPS. 2014 17 779 40 EFFECT OF YOGA AS ADD-ON THERAPY IN MIGRAINE (CONTAIN): A RANDOMIZED CLINICAL TRIAL. OBJECTIVE: TO EVALUATE THE EFFECTIVENESS OF YOGA AS AN ADJUVANT TO CONVENTIONAL MEDICAL MANAGEMENT ON CLINICAL OUTCOMES IN PATIENTS WITH MIGRAINE. METHODS: CONTAIN WAS A PROSPECTIVE, RANDOMIZED, OPEN-LABEL SUPERIORITY TRIAL WITH BLINDED ENDPOINT ASSESSMENT CARRIED OUT AT A SINGLE TERTIARY CARE ACADEMIC HOSPITAL IN NEW DELHI, INDIA. PATIENTS ENROLLED WERE AGED 18-50 YEARS WITH A DIAGNOSIS OF EPISODIC MIGRAINE AND WERE RANDOMIZED INTO MEDICAL AND YOGA GROUPS (1:1). RANDOMIZATION WAS COMPUTER-GENERATED WITH A VARIABLE BLOCK SIZE AND CONCEALED. A PREDESIGNED YOGA INTERVENTION WAS GIVEN FOR 3 MONTHS. OUTCOMES WERE RECORDED BY A BLINDED ASSESSOR. THE PRIMARY ENDPOINT WAS A DECREASE IN HEADACHE FREQUENCY, HEADACHE INTENSITY, AND HEADACHE IMPACT TEST (HIT)-6 SCORE. SECONDARY OUTCOMES INCLUDED CHANGE IN MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORE, PILL COUNT, AND PROPORTION OF HEADACHE FREE PATIENTS. RESULTS: BETWEEN APRIL 2017 AND AUGUST 2018, 160 PATIENTS WITH EPISODIC MIGRAINE WERE RANDOMLY ASSIGNED TO MEDICAL AND YOGA GROUPS. A TOTAL OF 114 PATIENTS COMPLETED THE TRIAL. BASELINE MEASURES WERE COMPARABLE EXCEPT FOR A HIGHER MEAN HEADACHE FREQUENCY IN THE YOGA GROUP. COMPARED TO MEDICAL THERAPY, THE YOGA GROUP SHOWED A SIGNIFICANT MEAN DELTA VALUE REDUCTION IN HEADACHE FREQUENCY (DELTA DIFFERENCE 3.53 [95% CONFIDENCE INTERVAL 2.52-4.54]; P < 0.0001), HEADACHE INTENSITY (1.31 [0.60-2.01]; P = 0.0004), HIT SCORE (8.0 [4.78-11.22]; P < 0.0001), MIDAS SCORE (7.85 [4.98-10.97]; P < 0.0001), AND PILL COUNT (2.28 [1.06-3.51]; P < 0.0003). CONCLUSION: YOGA AS AN ADD-ON THERAPY IN MIGRAINE IS SUPERIOR TO MEDICAL THERAPY ALONE. IT MAY BE USEFUL TO INTEGRATE A COST-EFFECTIVE AND SAFE INTERVENTION LIKE YOGA INTO THE MANAGEMENT OF MIGRAINE. CLINICALTRIALSGOV IDENTIFIER: CTRI/2017/03/008041. CLASSIFICATION OF EVIDENCE: THIS STUDY PROVIDES CLASS III EVIDENCE THAT FOR PATIENTS WITH EPISODIC MIGRAINE, YOGA AS ADJUVANT TO MEDICAL THERAPY IMPROVES HEADACHE FREQUENCY, INTENSITY, IMPACT, AND DISABILITY. 2020 18 2283 46 THE USE OF INTEGRATIVE THERAPY BASED ON YOGA AND AYURVEDA IN THE TREATMENT OF A HIGH-RISK CASE OF COVID-19/SARS-COV-2 WITH MULTIPLE COMORBIDITIES: A CASE REPORT. BACKGROUND: WE REPORT A HIGH-RISK CASE OF A CORONAVIRUS DISEASE 19 (COVID-19)-POSITIVE PATIENT WITH COMORBIDITIES INCLUDING DIABETES MELLITUS (DM), HYPERTENSION (HTN), HYPOTHYROIDISM AND CHRONIC KIDNEY DISEASE (CKD), TREATED SUCCESSFULLY USING AN INTEGRATIVE THERAPY PLAN BASED ON AYURVEDA AND YOGA, ALONG WITH GOVERNMENT-MANDATED COMPULSORY MODERN WESTERN MEDICINE (MWM) TREATMENT. RECENTLY, SOME EVIDENCE HAS BEEN EMERGING ON THE USE OF AYURVEDA FOR TREATMENT OF COVID-19. THE CLASSICAL TEXTS OF AYURVEDIC MEDICINE SUCH AS CHARAKA SAMHITA AND SUSHRUTA SAMHITA CONTAIN DESCRIPTIONS OF PANDEMICS OF SIMILAR PROPORTIONS AND DESCRIBE THEM AS JANAPADODDHVANSA, MEANING THE DESTRUCTION OF COMMUNITIES, ALONG WITH THEIR CAUSES AND TREATMENT. CASE PRESENTATION: THE CASE REPORTED HEREIN IS A 55-YEAR-OLD MAN FROM DELHI, INDIA, WITH CONFIRMED (TESTED) COVID-19, WHO FIRST TOOK MWM FOR 7 DAYS BEFORE SEEKING INTEGRATIVE THERAPY. THE PATIENT HAS COMORBIDITIES INCLUDING DM, HTN, HYPOTHYROIDISM AND CKD AND HAD DEVELOPED SYMPTOMS INCLUDING FEVER (WHICH WAS RESOLVED BY THE TIME INTEGRATIVE THERAPY WAS STARTED), SORE THROAT, DRY COUGH, BODY ACHES, WEAKNESS, BAD TASTE AND SMELL, AND HEAVINESS IN THE ABDOMEN. BASED ON THE PATIENT'S SYMPTOMS AND COMORBIDITIES, A TREATMENT PLAN INCLUDING AYURVEDIC MEDICINES, YOGA PROTOCOL, DIETARY RECOMMENDATIONS AND LIFESTYLE MODIFICATIONS WAS PRESCRIBED BY A REGISTERED AYURVEDA DOCTOR AND A YOGA CONSULTANT. THE PATIENT STARTED EXPERIENCING IMPROVEMENT IN ALL THE SYMPTOMS WITHIN 2 DAYS AFTER STARTING THE TREATMENT; HE REPORTED APPROXIMATELY [FORMULA: SEE TEXT] RELIEF FROM THE SYMPTOMS AFTER 5 DAYS, AND ALMOST COMPLETE RELIEF WITHIN 9 DAYS. ALSO, THE BLOOD SUGAR LEVELS (BOTH FASTING BLOOD SUGAR [FBS] AND POSTPRANDIAL BLOOD SUGAR [PPBS]) EXHIBITED SIGNIFICANT IMPROVEMENT AFTER 5 DAYS, AND DECREASED TO WITHIN THE NORMAL RANGE WITHIN 12 DAYS. BESIDES RELIEF IN SYMPTOMS, THE PATIENT'S REAL-TIME REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR) TEST DONE ON THE 19TH DAY RETURNED NEGATIVE RESULTS. CONCLUSIONS: INTEGRATIVE THERAPY WAS FOUND TO BE EFFECTIVE IN MITIGATING THE SYMPTOMS OF COVID-19 IN THIS PATIENT WITH MULTIPLE COMORBIDITIES. MOREOVER, A SIGNIFICANT IMPROVEMENT IN BLOOD SUGAR LEVELS (NOT UNDER CONTROL WITH MODERN MEDICINE) WAS ALSO ACHIEVED. INTEGRATIVE THERAPY BASED ON THE CLASSICAL TEXTS OF AYURVEDA AND YOGA MAY OFFER A PROMISING AND SCALABLE TREATMENT OPTION FOR COVID-19 PATIENTS. A CASE SERIES OR A SUITABLY DESIGNED RANDOMIZED CONTROLLED TRIAL IS NEEDED TO ASSESS ITS EFFICACY. 2021 19 754 35 EFFECT OF SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION ON PLASMA GLUCOSE LEVELS IN INDIVIDUALS WITH DIABETES AND PRE-DIABETES IN THE COMMUNITY. AIM: TO STUDY THE EFFECT OF SHORT TERM YOGA-BASED LIFESTYLE INTERVENTION IN THE MANAGEMENT OF DIABETES AND PRE-DIABETES, THROUGH A 'PILOT' COMMUNITY-BASED STUDY. METHODS: A TOTAL OF 1292 SUBJECTS WITH DIAGNOSED TYPE 2 DIABETES AND PRE-DIABETES WERE RECRUITED FROM DIFFERENT STATES OF INDIA VIZ., KARNATAKA, MAHARASHTRA, GUJARAT, RAJASTHAN, AND TAMILNADU PARTICIPATED IN THE STUDY. YOGA-BASED LIFESTYLE INTERVENTION WAS INTRODUCED THROUGH 10-DAY NON-RESIDENTIAL CAMPS. BASELINE AND POST INTERVENTION ASSESSMENTS OF FASTING PLASMA GLUCOSE (FPG) WERE MEASURED ON THE FIRST DAY AND TENTH DAY RESPECTIVELY. OF 1292 SUBJECTS, 896 BOTH PRE- AND POST- FPG READINGS WERE AVAILABLE. DATA ANALYSIS WAS DONE USING STATISTICAL PACKAGE FOR THE SOCIAL SCIENCES (SPSS), VERSION 16. RESULTS: MEAN BASELINE FPG LEVEL WAS 133.1 (+/-47.98) AND THE MEAN POST INTERVENTION FPG REDUCED TO 121.19 (+/-40.56). THERE WAS A STATISTICALLY SIGNIFICANT DECREASE IN FPG, P VALUE (<0.0001). CONCLUSION: THE RESULT SUGGESTS THAT A SHORT-TERM YOGA-BASED LIFESTYLE INTERVENTION EFFECTIVELY REDUCES FPG LEVELS IN TYPE 2 DIABETES PATIENTS AND PRE-DIABETES. 2017 20 959 40 EFFECTS OF A YOGA INTERVENTION ON LIPID PROFILES OF DIABETES PATIENTS WITH DYSLIPIDEMIA. OBJECTIVE: THE PRESENT STUDY WAS CONDUCTED TO ASSESS THE EFFECTIVENESS OF YOGA IN THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS OF TYPE 2 DIABETES MELLITUS. METHODS: THIS RANDOMIZED PARALLEL STUDY WAS CARRIED OUT IN MEDICAL COLLEGE TRIVANDRUM, KERALA, INDIA. HUNDRED TYPE 2 DIABETICS WITH DYSLIPIDEMIA WERE RANDOMIZED INTO CONTROL AND YOGA GROUPS. THE CONTROL GROUP WAS PRESCRIBED ORAL HYPOGLYCEMIC DRUGS. THE YOGA GROUP PRACTICED YOGA DAILY FOR 1 H DURATION ALONG WITH ORAL HYPOGLYCEMIC DRUGS FOR 3 MONTHS. THE LIPID PROFILES OF BOTH THE GROUPS WERE COMPARED AT THE START AND AT THE END OF 3 MONTHS. RESULTS: AFTER INTERVENTION WITH YOGA FOR A PERIOD OF 3 MONTHS THE STUDY GROUP SHOWED A DECREASE IN TOTAL CHOLESTEROL, TRIGLYCERIDES AND LDL, WITH AN IMPROVEMENT IN HDL. CONCLUSION: YOGA, BEING A LIFESTYLE INCORPORATING EXERCISE AND STRESS MANAGEMENT TRAINING, TARGETS THE ELEVATED LIPID LEVELS IN PATIENTS WITH DIABETES THROUGH INTEGRATED APPROACHES. 2013